NYSE American
LCTX
Lineage Cell Therapeutics, Inc.
- Health Care
- 1 day
- −0.9%
- 1 month
- −14.4%
- 1 year
- +14.2%
$1.13 · Mkt cap $282M
At the 6 Aug 2026 close
NYSE American
Lineage Cell Therapeutics, Inc.
$1.13 · Mkt cap $282M
At the 6 Aug 2026 close
Lineage Cell Therapeutics, Inc. trades under the ticker LCTX on NYSE American, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $282M. The last closing price was $1.13, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +14.2%, and −14.4% over the past month. Returns are price returns and exclude dividends.
This page exists because LCTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.